Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2019
DOI: 10.1007/s13760-019-01093-8
|View full text |Cite
|
Sign up to set email alerts
|

Clinical spectrum of the anti-GQ1b antibody syndrome: a case series of eight patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
1
3

Year Published

2020
2020
2022
2022

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 23 publications
0
13
1
3
Order By: Relevance
“…Anti-GQ1b or anti-GT1a have been identified in all cases. In addition, serum anti-GM1 was also detected in two cases 1 , 4 . Our patient would be the first described associated with isolated anti-GM1 positive titers…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…Anti-GQ1b or anti-GT1a have been identified in all cases. In addition, serum anti-GM1 was also detected in two cases 1 , 4 . Our patient would be the first described associated with isolated anti-GM1 positive titers…”
Section: Discussionmentioning
confidence: 90%
“…Anti-GQ1b or anti-GT1a have been identified in all cases. In addition, serum anti-GM1 was also detected in two cases 1,4 . Our patient would be the first described associated with isolated anti-GM1 positive titers J o u r n a l P r e -p r o o f Some potentially dangerous diseases may present with multiple or bilateral acute nerve palsies.…”
Section: J O U R N a L P R E -P R O O Fmentioning
confidence: 90%
“…It has also been reported that decreased vision, ophthalmoplegia and peripheral facial paralysis are the main manifestations [ 4 ]. Although there was more than one type of antibody in the patient’s serum, this situation is not rare according to related reports of anti-GQ1b antibody syndrome [ 5 7 ]. Due to their close structural relationship, anti-GT1a antibodies often cross-react with anti-GQ1b antibodies.…”
Section: Discussionmentioning
confidence: 92%
“…24 Anti-Gq1b syndromes manifest along a spectrum, ranging from the peripheral nervous system predominant Miller-Fisher syndrome (typified by the clinical triad of ataxia, areflexia and ophthalmoplegia) through to central involvement in the form of Bickerstaff's brainstem encephalitis, defined by a combination of external ophthalmoplegia AND either altered level of consciousness -ranging from mild drowsiness to coma-OR hyper-reflexia [25][26][27] with a multitude of forme frustes including acute ophthalmoparesis and acute ataxic neuropathy in between. 24,28 Up to 50 percent of patients with Bickerstaff's brainstem encephalitis have coexisting GBS, but limb weakness generally follows the development of ophthalmoplegia/ ataxia rather than being present at the onset. 27 Nerve conduction studies in these patients frequently demonstrate axonal involvement.…”
Section: Could the Gbs Treatment Be Responsible?mentioning
confidence: 99%
“…The next point to consider is whether the patient could be suffering from a related, but distinct disorder, particularly anti‐Gq1b antibody‐related disease 24 . Anti‐Gq1b syndromes manifest along a spectrum, ranging from the peripheral nervous system predominant Miller‐Fisher syndrome (typified by the clinical triad of ataxia, areflexia and ophthalmoplegia) through to central involvement in the form of Bickerstaff’s brainstem encephalitis, defined by a combination of external ophthalmoplegia AND either altered level of consciousness –ranging from mild drowsiness to coma‐ OR hyper‐reflexia 25–27 with a multitude of forme frustes including acute ophthalmoparesis and acute ataxic neuropathy in between 24,28 …”
Section: Am I Dealing With a Gbs Variant (Esp Anti‐gq1b Ssease)?mentioning
confidence: 99%